Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer

Junquan Song(Fudan University), Xiaowen Liu(Westlake University), Shiying Huo(Shanghai Medical College of Fudan University), Rongyuan Wei(Shanghai Academy of Social Sciences), Chenchen Liu(Shanghai Medical College of Fudan University)
Frontiers in Immunology
September 20, 2022
10.3389/fimmu.2022.960570
Cited by 31

Related Papers

Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response
|Nature Communications|2025|84
LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity
|Cancer Communications|2023|58
Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction
|Molecular Medicine|2022|39
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity
|Cancer Letters|2025|30
CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage
|OncoImmunology|2024|22